Gerresheimer CEO Uwe Röhrhoff will not extend his contract
Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG, informed Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG, that after expiry of his contract in February 2018 he will not be available for an extension of his contract for personal reasons.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Clavis Pharma receives US Orphan Drug Designation for CP-4126 to treat pancreatic cancer

Nuevolution A/S - Kopenhagen, Denmark
Amgen Announces FDA Licensure of Two New Manufacturing Facilities - Company Continues to Meet Increased Demand for Its Novel Therapeutics
Drug-induced cellular membrane complexes induce cancer cell death - New sub-cellular complex discovered
Fraunhofer-Institut für Biomedizinische Technik (IBMT) - Potsdam, Germany
DIREVO and Pfizer collaborate on therapeutic proteases
Sun Pharma to acquire Pola Pharma
Domainex appoints Timo Veromaa as Executive Chairman

Thyroid tumour: it takes two to tango
